CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma (vol 72, pg 962, 2017)

Escudier, B; Sharma, P; McDermott, DF; George, S; Hammers, HJ; Srinivas, S; Tykodi, SS; Sosman, JA; Procopio, G; Plimack, ER; Castellano, D; Gurney, H; Donskov, F; Peltola, K; Wagstaff, J; Gauler, TC; Ueda, T; Zhao, HY; Waxman, IM; Motzer, RJ

Escudier, B (reprint author), Inst Gustave Roussy, Villejuif, France.; Escudier, B (reprint author), Gustave Roussy, 114 Rue Edouard Vaillant, F-94800 Villejuif, France.

EUROPEAN UROLOGY, 2018; 73 (4): E116